Psychiatr. pro Praxi, 2009; 10(3): 130-134

Complex antidepressant effect and pain

MUDr. Marek Páv
Psychiatrická léčebna Horní Beřkovice

Pain and depression are pathological states influenced by serotonergic and noradrenergic system functioning. In the treatment of both

states are used drugs, affecting both neurotransmitter systems. In the chronic pain pathogenesis besides neuronal system changes takes

place also glial cell activation, which can endure acute pain stimulus and participate in the pain chronification. Antidepressant treatment

is affecting depressive syndrome and pain affective and cognitive component due neuroplastic processes modulation. Inflammatory

mediators can activate stress axis and influence neurotransmitter metabolism during chronic pain states, antidepressants diminish

inflammatory molecule production on the periphery and in the central nervous system, uncoupling thus stress axis activation.

Keywords: pain, depression, antidepressant, microglia, astrocyte, cytokine, neuroplasticity.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Páv M. Complex antidepressant effect and pain. Psychiatr. praxi. 2009;10(3):130-134.
Download citation

References

  1. Lépine JP, Briley M. The epidemiology of pain in depression. Hum Psychopharmacol 2004; 19: S3-7. Go to original source... Go to PubMed...
  2. Burt VK. Plotting the course to remission: the search for better outcomes in the treatment of depression. J Clin Psychiatry 2004; 65(suppl 12): 20-25.
  3. Maršálek M. Komorbidita deprese a bolesti. Psychiat pro Praxi 2007; 2: 77-80.
  4. Millan MJ. Induction of pain: integrative review. Prog Neurobiol. 1999; 57: 1-154. Go to original source... Go to PubMed...
  5. Rokyta R. Neuroanatomie bolesti. Psychiatrie 2006; 10: 46-49.
  6. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in, ,small" glia. Trend Neurosci 2005; 28: 101-107. Go to original source... Go to PubMed...
  7. May A. Chronic pain may chase the structure of the brain. Pain 2008; 137: 7-15. Go to original source... Go to PubMed...
  8. Fishbain DA, Cutler R, Rosomoff RS. Evidence-based from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000; 1: 310-316. Go to original source... Go to PubMed...
  9. Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol Clin Exp. 2004; 19: S15-19. Go to original source... Go to PubMed...
  10. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007 Oct 17; (4): CD005454. Go to original source... Go to PubMed...
  11. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-118. Go to original source... Go to PubMed...
  12. Briley M. Clinical experience with dual action antidepressant in different pain syndromes. Hum Psychopharmacol (2004); 19(suppl): S21-25. Go to original source... Go to PubMed...
  13. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006; 80: 53-83. Go to original source... Go to PubMed...
  14. Navarro X. Neural plasticity after peripheral nerve injury and regeneration. Prog Neurobiol 2007; 82: 163-201. Go to original source... Go to PubMed...
  15. DeLeo JA, Tawfik VL, LeCroiix-Fralish ML. The tetrapartite synapse: Path to CNS sensitization and chronic pain. Pain 2006; 122: 17-21. Go to original source... Go to PubMed...
  16. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for neuropathic pain. Trends Neurosci 2001; 24(8): 450-455. Go to original source... Go to PubMed...
  17. Kovářů H, Kovářů F. Základy neuroimmunomodulace 1. vydání, Galén: Praha 2005: 203-208.
  18. Perea G, Araque A. Glial calcium signalling and neuronglia communication. Cell Calcium. 2005; 38: 375-382. Go to original source... Go to PubMed...
  19. Páv M, Kovářů H, Fišerová A, Havrdová E, Lisá V. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. Physiol Res. 2008; 57(2): 151-164. Go to original source...
  20. Hutchinson MR, Coats BD, Lewis SS, et al. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun (2008) Jul 1 Epub ahead of print. Go to original source... Go to PubMed...
  21. Milligan ED, Sloane EM, Watkins LR. Glia in pathological pain: A role for fractalkine. J Neuroimmunol 2008; 198: 113-120. Go to original source... Go to PubMed...
  22. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59(12): 1116-1127. Go to original source... Go to PubMed...
  23. Nestler EJ, Barrot M, DiLeone RJ, et al. Neurobiology of depression. Neuron 2002; 34: 13-25. Go to original source... Go to PubMed...
  24. Merighi A, Salio C, Ghirri A, et al. BDNF as a pain modulator. Prog Neurobiol 2008; 85: 297-317. Go to original source... Go to PubMed...
  25. Haddad JJ, Saadé NE, Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 2002; 133: 1-19. Go to original source... Go to PubMed...
  26. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008; 85(1): 1-74. Go to original source... Go to PubMed...
  27. Song C, Leonard BE. Základy psychoneuroimunologie. 1. vydání, Artax Brno 2002.
  28. Bianchi M. Effect of clomipramine and fluoxetine on subcutaneous carregeenin-induced inflammation in the rat. Inflamm Res. 1995; 44: 466-469. Go to original source... Go to PubMed...
  29. Wichers MC, Maes M. The role of indoleamine 2, 3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression, J Psychiatry Neurosci 2005; 10(6): 538-544. Go to original source... Go to PubMed...
  30. Sudoh Y, Cahoon EE, Gerner P, Wang GK. Tricyclic antidepressants as long-acting anaesthetics. Pain 2003; 103: 49-55. Go to original source... Go to PubMed...
  31. Chen YW, Huang KL, Liu SY, et al. Intrathecal tri-cyclic antidepressants produce spinal anaesthesia. Pain 2004; 112(1-2): 106-112. Go to original source... Go to PubMed...
  32. Inazu M, Takeda H, Ikoshi H, et al. Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem Int 2001; 39(1): 39-49. Go to original source... Go to PubMed...
  33. Inazu M, Takeda H, Matsumiya T. Functional expression of the norepinephrine transporter in cultured rat astrocytes. J Neurochem 2003; 84(1): 136-144. Go to original source... Go to PubMed...
  34. Storm SM, Khawaja XZ. Probing for drug-induced multiplex signal transduction pathways using high resolution twodimensional gel electrophoresis: application to beta-adrenoreceptor stimulation in the rat C6 glioma cell. Brain Res Mol Brain Res.1999; 71: 50-60. Go to original source... Go to PubMed...
  35. Feinstein DL, Heneka MT, Gavrilyuk V, et al. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int 2002; 41: 357-365. Go to original source... Go to PubMed...
  36. Hwang J, Zheng LT, Ock J, et al. Inhibition of glial activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008; 55: 826-834. Go to original source... Go to PubMed...
  37. Hashioka S, Klegeris A, Monji A, et al. Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol 2007; 206: 33-42. Go to original source... Go to PubMed...
  38. Vollmar P, Haghikia A, Dermietzel R, et al. Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol 2008; 11: 111-117. Go to original source... Go to PubMed...
  39. Banasr M, Duman R. Glial loss in the Prefrontal Cortex Is Sufficient to induce depressive-like Behaviours. Biol Psychiatry 2008; 64(10): 863-870. Go to original source... Go to PubMed...
  40. Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007; 6: 219-233. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.